Eupraxia Pharmaceuticals (EPRX) Earnings Analysis
Eupraxia Pharmaceuticals (EPRX) has no confirmed upcoming earnings date. Last quarter (2026-03-12) it missed with EPS -0.37 USD vs -0.16 USD est (-131.3%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -6.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EPRX next report earnings?
No confirmed upcoming earnings date is currently scheduled for EPRX. This page updates as the calendar is published.
EPRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -0.37 USD | -0.16 USD | -131.3% | Miss |
| 2025-03-20 | -0.21 USD | -0.18 USD | -16.7% | Miss |
| 2024-11-07 | -0.17 USD | -0.13072 USD | -30% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
EPRX valuation and analyst view
| Trailing P/E | -6.15 |
|---|---|
| Trailing EPS | -0.78495 USD |
| Price / book | 2.66 |
| Dividend yield | 0.00% |
| Market cap | 0.22B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 17 USD |
Related research pages
Frequently asked questions
When is Eupraxia Pharmaceuticals (EPRX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for EPRX. This page updates as the calendar is published.
Did EPRX beat earnings last quarter?
In its 2026-03-12 report, EPRX posted EPS of -0.37 USD versus a -0.16 USD estimate — a miss of 131.3%.
What is EPRX's earnings track record?
Over the last 3 reported quarters with consensus data, EPRX beat estimates 0 times (0%).
What is EPRX's current P/E ratio and EPS?
EPRX trades at a trailing P/E of -6.15 on trailing EPS of -0.7849478980200246 USD.
What do analysts rate EPRX?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.